90
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15079 |
DBPR108
|
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
DBPR108是新型、具有口服活性、选择性的DPP4抑制剂,IC50=为15nM,对DPP8和DPP9基本无抑制。 | |||
T1502 |
Vildagliptin
维达列汀,NVP-LAF 237,维格列汀,LAF237 |
Apoptosis; Ferroptosis; Proteasome; DPP-4 | Apoptosis; Proteases/Proteasome; Ubiquitination |
Vildagliptin (LAF237) 是一种选择性二肽基肽酶IV (DPP-IV) 抑制剂,在人 Caco-2 细胞中抑制 DPP-IV 的IC50为 3.5 nM。它具有出色的口服生物利用度和降血糖活性。 | |||
T7369 |
Gemigliptin
吉格列汀酒石酸盐,LC15-0444 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Gemigliptin (LC15-0444) 是一种选择性的,可逆的,竞争性的二肽基肽酶 4 (DPP-4) 抑制剂,对人重组 DPP-4 的 IC50=10.3 nM。Gemigliptin 具有很强的抗糖基化活性,能够用于晚期糖基化终产物相关的糖尿病并发症的研究。 | |||
T7369L |
Gemigliptin Tartrate(911637-19-9 free base)
吉格列汀酒石酸盐,LC15-0444 tartrate |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Gemigliptin Tartrate (LC15-0444 tartrate) 是一种选择性的,可逆的,竞争性的二肽基肽酶 4 (DPP-4) 抑制剂,对于人重组 DPP-4 的IC50=10.3 nM。Gemigliptin tartrate 具有很强的抗糖基化活性,能够用于晚期糖基化终产物相关的糖尿病并发症的研究。 | |||
T0242 |
Sitagliptin
西他列汀,MK0431,西格列汀 |
Proteasome; DPP-4; Autophagy | Autophagy; Proteases/Proteasome; Ubiquitination |
Sitagliptin (MK0431) 是一种有效的 DPP4抑制剂,在 Caco-2 细胞中,IC50值为 19 nM。它是一种新型口服降糖药,可单独使用或与二甲双胍或噻唑烷二酮联合用于治疗 2 型糖尿病。 | |||
T4042 |
Talabostat mesylate
Val-boroPro,PT100 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Talabostat mesylate (PT100) 是一种具有口服活性和非选择性的二肽基肽酶 IV 抑制剂(IC50< 4 nM;Ki= 0.18 nM)。Talabostat mesylate 是成纤维细胞活化蛋白的第一个临床抑制剂(IC50= 560 nM),抑制 DPP8/9 (IC50= 4/11 nM;Ki= 1.5/0.76 nM),静息细胞脯氨酸二肽酶(IC50= 310 nM)、DPP2 和一些其他 DASH 家族酶。Talabostat mesylate 具有抗肿瘤和造血刺激活性 。 | |||
T0191 |
Linagliptin
BI 1356,利格列汀,利拉利汀 |
Ferroptosis; Proteasome; DPP-4; Autophagy | Apoptosis; Autophagy; Proteases/Proteasome; Ubiquitination |
Linagliptin (BI 1356) 是一种有效的、可口服的、基于二氢嘌呤二酮的二肽基肽酶 4 抑制剂,具有降血糖活性。 | |||
T6237 |
Trelagliptin
SYR-472,曲格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Trelagliptin (SYR-472) 是一种有效的,具有口服活性的DPP-4抑制剂,IC50=4 nM。它可以改善体内血糖控制,能够用于2 型糖尿病 (T2DM) 的研究。 | |||
TQ0038 |
Brensocatib
AZD7986,INS 1007 |
Proteasome | Proteases/Proteasome; Ubiquitination |
Brensocatib (AZD7986) 是一种二肽基肽酶 1 (DPP1) 抑制剂,在人,小鼠,大鼠,狗和兔中的pIC50分别为 6.85, 7.6, 7.7, 7.8 和 7.8。 | |||
T6192 |
Alogliptin
SYR-322,阿格列汀,阿洛利停 |
Ferroptosis; Proteasome; DPP-4 | Apoptosis; Proteases/Proteasome; Ubiquitination |
Alogliptin (SYR-322) 是一种具有选择性口服活性的DPP-4的抑制剂,IC50值小于 10 nM,比对 DPP-8 和 DPP-9 的抑制性高 10000 倍以上,可研究 2 型糖尿病。 | |||
T11526 |
DPP-IV-IN-2
H-Lys(4-nitro-Z)-pyrrolidide |
DPP-4 | Proteases/Proteasome |
DPP-IV-IN-2 (H-Lys(4-nitro-Z)-pyrrolidide) 是二肽基肽酶 IV 和DP8/9的抑制剂, IC50分别为 0.1 和 0.95 μM。 | |||
T25340 |
Diprotin A
Ile-Pro-Ile,抑二肽素A |
DPP-4 | Proteases/Proteasome |
Diprotin A (Ile-Pro-Ile) 是二肽基肽酶 IV (DPP-IV) 的抑制剂。 | |||
T16684 |
Puromycin aminonucleoside
维生素E醋酸酯,NSC 3056 |
Apoptosis; Proteasome; Aminopeptidase; Antibacterial; Antibiotic | Apoptosis; Metabolism; Microbiology/Virology; Proteases/Proteasome; Ubiquitination |
Puromycin aminonucleoside (NSC-3056) 是一种氨基核苷类抗生素,是嘌呤霉素类似物。它可逆抑制二肽基肽酶和胞浆丙氨酸氨基肽酶。它通过以氧化应激依赖性方式调节 ZO-1 来增加足细胞通透性。它诱导细胞凋亡 。 | |||
T12710 |
Retagliptin Phosphate
SP 2086,瑞格列汀磷酸盐 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Retagliptin Phosphate (SP 2086) 是一种选择性、竞争性、口服活性的二肽基肽酶 4 (DPP-4) 抑制剂。Retagliptin phosphate 能够用于 2 型糖尿病 (T2DM) 的研究。 | |||
T4467 |
UAMC00039 dihydrochloride
UAMC 00039 dihydrochloride |
Proteasome | Proteases/Proteasome; Ubiquitination |
UAMC00039 dihydrochloride 是可逆、竞争性的 dipeptidyl peptidase II 高效抑制剂,IC50=为0.48 nM。 | |||
T6999 |
Teneligliptin hydrobromide
Teneligliptin hydrobromide anhydrous,MP-513 (hydrobromide) |
Others; Proteasome; DPP-4 | Others; Proteases/Proteasome; Ubiquitination |
Teneligliptin hydrobromide (MP-513(hydrobromide)) 是β2肾上腺素能受体 (β2AR) 阻滞剂,具有抗高血压、抗氧化、清除自由基的活性。 | |||
T1674 |
Nateglinide
那格列奈,A4166,Senaglinide |
Potassium Channel; Proteasome; PPAR | DNA Damage/DNA Repair; Membrane transporter/Ion channel; Metabolism; Proteases/Proteasome; Ubiquitination |
Nateglinide (Senaglinide) 是 D-苯丙氨酸的一种衍生物,是口服有效的、短效促胰岛素释放化合物,也是 DPP IV 抑制剂。 Nateglinide 抑制胰岛 β 细胞中 ATP 敏感的 K+通道。Nateglinide 在 2 型糖尿病中具有研究价值。 | |||
T7133 |
Anagliptin
SK-0403,阿拉格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Anagliptin (SK-0403) 是一种选择性的二肽酰肽酶 4 抑制剂,IC50=3.8 nM,对 DPP-8/9 的选择性相对较弱,IC50分别为 68 和 60 nM。 | |||
T2316 |
Omarigliptin
MK-3102,奥格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Omarigliptin (MK-3102) 是高效选择性 DPP4抑制剂,IC50=为1.6nM。 | |||
T8550 |
NDMC101
|
Others; NF-κB; Proteasome | NF-κB; Others; Proteases/Proteasome; Ubiquitination |
NDMC101 是有效的破骨细胞形成抑制剂,通过下调 NFATc1 调控基因表达抑制破骨细胞分化。它与 DPP4底物相似,通过抑制DPP4抑制早期 T 细胞激活。它能够用于骨疾病的研究,如类风湿关节炎、滑膜炎等。 | |||
T23358 |
Sitagliptin phosphate
磷酸西他列汀,Januvia,MK-0431 phosphate,Sitagliptin (phosphate) |
DPP-4; Autophagy | Autophagy; Proteases/Proteasome |
Sitagliptin phosphate (MK-0431 phosphate) 是一种二肽基肽酶 4 (DPP4) 抑制剂,在 Caco-2 细胞中,IC50值为 19 nM。 | |||
T2401 |
Alogliptin Benzoate
苯甲酸阿格列汀,SYR 322,Alogliptin(SYR-322)benzoate |
Ferroptosis; Proteasome; DPP-4 | Apoptosis; Proteases/Proteasome; Ubiquitination |
Alogliptin Benzoate (SYR 322) 是一种有效且特异性的 DPP-4 抑制剂 ,IC50值小于 10 nM,其选择性比 DPP-8/9 高 10,000 倍以上,可用于研究 2 型糖尿病。 | |||
T6203 |
Saxagliptin
BMS-477118,沙克列汀,Onglyza,沙格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Saxagliptin (BMS-477118) 是一种选择性,可逆性,竞争性和口服活性的二肽基肽酶 4 (DPP-4) (Ki= 0.6-1.3 nM) 抑制剂。Saxagliptin 能够用于 2 型糖尿病的研究。 | |||
T2296 |
Trelagliptin succinate
曲格列汀琥珀酸盐,琥珀酸曲格列汀,SYR-472 succinate,SYR472 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Trelagliptin succinate (SYR-472 succinate) 是一种有效的,具有口服活性的DPP-4抑制剂,IC50=4 nM。它可以改善体内血糖控制,能够用于2 型糖尿病(T2DM) 的研究。 | |||
T0242L |
Sitagliptin phosphate monohydrate
MK-0431,MK-0431 phosphate monohydrate,西他列汀磷酸盐一水合物 |
Proteasome; DPP-4; Autophagy | Autophagy; Proteases/Proteasome; Ubiquitination |
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) 是一种有效的 DPP-IV 抑制剂,在 Caco-2 细胞提取物中的 IC50 为 19 nM。 | |||
T0178 |
Saxagliptin hydrate
沙格列汀单水化合物,Onglyza hydrate,BMS-477118 hydrate |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Saxagliptin hydrate (Onglyza hydrate) 是一种选择性,竞争性,可逆性和口服活性的二肽基肽酶 4 (DPP-4) (Ki= 0.6-1.3 nM) 抑制剂。Saxagliptin hydrate 能够用于 2 型糖尿病的研究。 | |||
T36583 |
Gly-Pro-pNA hydrochloride
Gly-Pro p-nitroanilide hydrochloride |
Proteasome | Proteases/Proteasome; Ubiquitination |
Gly-Pro-pNA hydrochloride (Gly-Pro p-nitroanilide hydrochloride)是一种二肽基肽酶抑制剂,对二肽基肽酶II、二肽基肽酶IV和二肽基肽酶IX具有抑制作用。 | |||
T78410 |
Gly-Pro-AMC hydrobromide
Gly-Pro-AMC HCl |
||
Gly-Pro-AMC hydrobromide (Gly-Pro-AMC HCl) 为特异性荧光染料,用于细胞荧光检测,检测 Dipeptidyl peptidase IV (DPP-IV) 活性。 | |||
T67852 |
Linagliptin Methyldimer
|
Proteasome | Proteases/Proteasome; Ubiquitination |
Linagliptin Methyldimer 是一种强效的二肽基肽酶 IV 抑制剂,IC50=6 pM。 | |||
T29019 |
TS-021
TS021,TS 021,TS-021 Free |
DPP-4 | Proteases/Proteasome |
TS-021 是一种具有选择性的二肽基肽酶 4 (DPP-4) 抑制剂,具有抗糖尿病活性,可用于研究2 型糖尿病。 | |||
T78223 |
γ-Glu-Tyr
gamma-Glutamyltyrosine,gamma-GLU-TYR |
||
γ-Glu-Tyr (gamma-Glutamyltyrosine) 是一种对二肽基肽酶-IV (DPP-IV) 具有竞争性抑制作用的 kokumi 肽,可用于研究糖尿病。 | |||
T68053 |
Denagliptin
GW823093 |
DPP-4 | Proteases/Proteasome |
Denagliptin是一种小分子二肽基肽酶IV(DPP-4)抑制剂,可用于治疗内分泌于代谢疾病,可用于研究2型糖尿病。 | |||
T21979 |
P32/98 (hemifumarate)
|
||
P32/98 hemifumarate 为二肽基肽酶 IV (DPP4) 抑制剂,可在Zucker糖尿病大鼠模型中改善葡萄糖耐量、提高胰岛素敏感性及增强β细胞反应性,具有预防2型糖尿病的潜力。 | |||
T25341 |
Diprotin B
|
||
Diprotin B is a dipeptidyl peptidase IV inhibitor. | |||
T22886 |
K 579
|
Others | Others |
K 579 is a dipeptidyl peptidase IV inhibitor. | |||
T27353 |
Fotagliptin
|
||
Fotagliptin is a dipeptidyl peptidase IV inhibitor. | |||
T70254 |
FE-999011
|
||
FE-999011 is a dipeptidyl peptidase IV inhibitor. | |||
T26850 |
BMS-538305 HCl
BMS-538305,BMS538305,BMS 538305,BMS-538305 hydrochloride |
||
BMS-538305 is a potent, selective inhibitor of dipeptidyl peptidase IV (DPP-IV). | |||
T25382 |
Epostatin
|
||
Epostatin is a new dipeptidyl peptidase II (DPP-II, EC 3.4.14.2) inhibitor. | |||
T11450 |
Gosogliptin
PF-00734200,PF-734200 |
Others | Others |
Gosogliptin is a potent and selective dipeptidyl peptidase-IV (DPP-IV) inhibitor. | |||
T26941 |
Camegliptin
RO-4876904-001,R1579,RG1579,RO-4876904,R-1579,RG-1579 |
||
Cameglipti, a dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type 2 diabetes. | |||
T30166 |
ASP-4000 HCl
ASP4000 HCl,ASP 4000 HCl,UNII-7393JFE67B |
||
ASP-4000 HCl is an inhibitor of dipeptidyl peptidase 4 (DPP) with anti-hyperglycemic activity. | |||
T27598 |
Imigliptin Dihydrochloride
Imigliptin |
||
Imigliptin Dihydrochloride, a selective dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type II diabetes. | |||
T11049 |
Diprotin A TFA
Ile-Pro-Pro (TFA) |
Others | Others |
Diprotin A (TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV). | |||
T10082 |
DPP-IV-IN-1
|
Others | Others |
DPP-IV-IN-1 is an effective inhibitor of dipeptidyl peptidase IV (DPP-IV), a serine protease (IC50: 4.6 nM). | |||
T13826 |
Prodipine hydrochloride
|
Others | Others |
Prodipine hydrochloride for purified and plasma Dipeptidyl peptidase IV (DPP IV) from the rabbit (IC50 of 4.5 μM and 30 μM, respectively). | |||
T31378 |
Denagliptin tosylate
GSK-823093,GSK 823093,GW-823093,GW 823093,GSK823093,GW823093 |
||
Denagliptin (GW823093 or GSK-823093) is a dipeptidyl peptidase IV (DPP-IV) inhibitor. | |||
T68561 |
ASP-4000 free base
|
||
ASP-4000 free base is a dipeptidyl peptidase 4 (DPP) inhibitor with antihyperglycemic activity. | |||
T71117 |
AZD5248
|
||
AZD-5248 is a potent, selective, first generation, oral inhibitor of dipeptidyl peptidase 1 (DPP1). | |||
T22747 | DPPI 1c hydrochloride | Others | Others |
DPPI 1c hydrochloride is an inhibitor of dipeptidyl peptidase IV (IC50 = 104 nM) that shows selectivity over enzymes with DPP-like activity (IC50 > 30 μM). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T16838 |
Saikogenin A
|
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Saikogenin A 是一种二肽基肽酶 IV 抑制剂,可从中药柴胡中提取。 | |||
TN1418 |
Azaleatin
杜鹃黄素,2-(3,4-二羟基苯基)-3,7-二羟基-5-甲氧基苯并吡喃-4-酮 |
DPP-4 | Proteases/Proteasome |
Azaleatin 是分离自Rhododendron 种中的 O-甲基化黄酮醇。它是二肽基肽酶-IV 的抑制剂。它在 2 型糖尿病和肥胖症中有研究的价值。 | |||
T39219 | Ficusonolide | ||
Ficusonolide exhibits significant antidiabetic activity through its interactions with dipeptidyl peptidase-IV (DPP-IV), protein tyrosine phosphatase 1B (PTP-1B), α-glucosidase, and α-amylase. | |||
T75493 | Ellipyrone B | ||
Ellipyrone B,一种大环肽,对二肽基肽酶 4 (dipeptidyl peptidase-4: IC50=0.48 mM) 表现出抑制作用。 | |||
T75492 | Ellipyrone A | ||
Ellipyrone A为一种大环肽,对二肽基肽酶 4 (dipeptidyl peptidase-4: IC50=0.35 mM) 显示出抑制活性,并对α-葡萄糖苷酶 (IC50=0.74 mM) 及α-淀粉酶 (IC50=0.59 mM) 也具有明显的抑制效果,表现出其抗碳水化合物分解的性能。 | |||
T83863 |
Fluostatin A sodium
|
||
Fluostatin A是一种最初从链霉菌中分离出的荧光酮类化合物。它对二肽基肽酶3(DPP-3)的选择性抑制作用优于对DPP-1、DPP-2和DPP-4的抑制作用(IC50s分别为0.44, >100, >100, 和 >100 µg/ml)。 | |||
T81898 |
Lyciumamide A
|
||
DPP-IV-IN-5,一种从枸杞果实中分离得到的化合物,对过氧化物酶体增殖物激活受体(PPARγ)展示中等拮抗活性,其EC50值介于10.09至44.26 μM,同时对二肽基肽酶-4 (DPPIV)亦有抑制作用,IC50值为47.13 μM。 |